Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors
dc.article.end-page | 86 | en |
dc.article.start-page | 78 | en |
dc.citation.doi | 10.1111/HAE.15109 | en |
dc.contributor.author | A Dunn | en |
dc.contributor.author | Y Dargaud | en |
dc.contributor.author | y Abajas | en |
dc.contributor.author | M Carcao | en |
dc.contributor.author | E et al | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.date.accessioned | 2025-08-26T10:02:20Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 1351-8216 | en |
dc.identifier.uri | https://hdl.handle.net/10539/46069 | |
dc.journal.title | Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors | en |
dc.journal.volume | 31 | en |
dc.title | Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 672.41 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client